Literature DB >> 8287997

The effect of acetazolamide on the retinal circulation.

S M Rassam1, V Patel, E M Kohner.   

Abstract

The effect of the carbonic anhydrase inhibitor, acetazolamide, on the retinal circulation was studied in 10 healthy volunteers. Acetazolamide was administered intravenously at a dose of 500 mg. Retinal blood flow was determined from red cell velocity using laser Doppler velocimetry and vessel diameter measurement using computerised digital image analysis of monochromatic fundus photographs. There was a significant increase in retinal blood flow at 30 minutes and 60 minutes after acetazolamide injection (p = 0.002). Retinal vessels showed vasodilatation reaching significant levels 60 minutes after the injection (p < 0.03). An increase in red cell velocity was observed at 30 and 60 minutes (p < 0.002). A significant reduction in intraocular pressure occurred at 30 and 60 minutes after the injection (p < 0.001). The mechanisms responsible for the increase in retinal blood flow acted via significant increases in perfusion pressure (p < 0.05), red cell velocity (p < 0.002) and retinal vessel dilatation (p < 0.03). An increase in tissue PCO2 and a reduction in pH are thought to be responsible for the vascular dilatation. The increase in retinal blood flow with acetazolamide may serve to limit optic disc and retinal ischaemia in acute glaucoma and central retinal artery occlusion respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287997     DOI: 10.1038/eye.1993.159

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  18 in total

1.  In vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature.

Authors:  P Pickkers; A D Hughes; F G Russel; T Thien; P Smits
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  Hypertension and the eye.

Authors:  James S Wolffsohn; Peter G Hurcomb
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

Review 3.  A review of central retinal artery occlusion: clinical presentation and management.

Authors:  D D Varma; S Cugati; A W Lee; C S Chen
Journal:  Eye (Lond)       Date:  2013-03-08       Impact factor: 3.775

4.  Acute retinal arterial ischemia.

Authors:  Michael Dattilo; Nancy J Newman; Valérie Biousse
Journal:  Ann Eye Sci       Date:  2018-06-06

Review 5.  Pharmacotherapy of glaucoma.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-14       Impact factor: 2.671

6.  Carbonic anhydrase inhibition increases retinal oxygen tension and dilates retinal vessels.

Authors:  Daniella Bach Pedersen; Peter Koch Jensen; Morten la Cour; Jens Folke Kiilgaard; Thor Eysteinsson; Kurt Bang; Anne Kathrine Wiencke; Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-30       Impact factor: 3.117

7.  Indomethacin lowers optic nerve oxygen tension and reduces the effect of carbonic anhydrase inhibition and carbon dioxide breathing.

Authors:  D B Pedersen; T Eysteinsson; E Stefánsson; J F Kiilgaard; M La Cour; K Bang; P K Jensen
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

8.  Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients.

Authors:  Adam M Moss; Alon Harris; Brent Siesky; Deepam Rusia; Kathleen M Williamson; Yochai Shoshani
Journal:  Clin Ophthalmol       Date:  2010-04-26

9.  The effect of latanoprost on ocular blood flow.

Authors:  Alon Harris; Hanna J Garzozi; Lynne McCranor; Ehud Rechtman; Chi-Wah Yung; Brent Siesky
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

10.  Effects of brinzolamide on ocular haemodynamics in healthy volunteers.

Authors:  M Kaup; N Plange; M Niegel; A Remky; O Arend
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.